Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
PRO, Barbara, ADVANI, Ranjana, YIN YANG, SIEVERS, Eric L, KENNEDY, Dana A, SHUSTOV, Andrei, BRICE, Pauline, BARTLETT, Nancy L, ROSENBLATT, Joseph D, ILLIDGE, Tim, MATOUS, Jeffrey, RAMCHANDREN, Radhakrishnan, FANALE, Michelle, CONNORS, Joseph M
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, Anas, Bartlett, Nancy L, Leonard, John P, Kennedy, Dana A, Lynch, Carmel M, Sievers, Eric L, Forero-Torres, Andres
Published in The New England journal of medicine (04.11.2010)
Published in The New England journal of medicine (04.11.2010)
Get full text
Journal Article
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
YOUNES, Anas, GOPAL, Ajay K, FORERO-TORRES, Andres, MOSKOWITZ, Craig H, CONNORS, Joseph M, ENGERT, Andreas, LARSEN, Emily K, KENNEDY, Dana A, SIEVERS, Eric L, CHEN, Robert, SMITH, Scott E, ANSELL, Stephen M, ROSENBLATT, Joseph D, SAVAGE, Kerry J, RAMCHANDREN, Radhakrishnan, BARTLETT, Nancy L, CHESON, Bruce D, DE VOS, Sven
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
Pro, Barbara, Advani, Ranjana, Brice, Pauline, Bartlett, Nancy L., Rosenblatt, Joseph D., Illidge, Tim, Matous, Jeffrey, Ramchandren, Radhakrishnan, Fanale, Michelle, Connors, Joseph M., Fenton, Keenan, Huebner, Dirk, Pinelli, Juan M., Kennedy, Dana A., Shustov, Andrei
Published in Blood (21.12.2017)
Published in Blood (21.12.2017)
Get full text
Journal Article
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
Horwitz, Steven M., Advani, Ranjana H., Bartlett, Nancy L., Jacobsen, Eric D., Sharman, Jeff P., O'Connor, Owen A., Siddiqi, Tanya, Kennedy, Dana A., Oki, Yasuhiro
Published in Blood (15.05.2014)
Published in Blood (15.05.2014)
Get full text
Journal Article
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Jacobsen, Eric D., Sharman, Jeff P., Oki, Yasuhiro, Advani, Ranjana H., Winter, Jane N., Bello, Celeste M., Spitzer, Gary, Palanca-Wessels, Maria Corinna, Kennedy, Dana A., Levine, Pamela, Yang, Jing, Bartlett, Nancy L.
Published in Blood (26.02.2015)
Published in Blood (26.02.2015)
Get full text
Journal Article
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study
Fanale, Michelle A, Horwitz, Steven M, Forero-Torres, Andres, Bartlett, Nancy L, Advani, Ranjana H, Pro, Barbara, Chen, Robert W, Davies, Andrew, Illidge, Tim, Huebner, Dirk, Kennedy, Dana A, Shustov, Andrei R
Published in Journal of clinical oncology (01.10.2014)
Published in Journal of clinical oncology (01.10.2014)
Get full text
Journal Article
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas
Fanale, Michelle A., Horwitz, Steven M., Forero-Torres, Andres, Bartlett, Nancy L., Advani, Ranjana H., Pro, Barbara, Chen, Robert W., Davies, Andrew, Illidge, Tim, Uttarwar, Mayur, Lee, Shih-Yuan, Ren, Hong, Kennedy, Dana A., Shustov, Andrei R.
Published in Blood (10.05.2018)
Published in Blood (10.05.2018)
Get full text
Journal Article
A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies
FANALE, Michelle A, FORERO-TORRES, Andres, ROSENBLATT, Joseph D, ADVANI, Ranjana H, FRANKLIN, AnnaR, KENNEDY, Dana A, HAN, Tae H, SIEVERS, Eric L, BARTLETT, Nancy L
Published in Clinical cancer research (2012)
Published in Clinical cancer research (2012)
Get full text
Journal Article
A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma
Forero‐Torres, Andres, Leonard, John P., Younes, Anas, Rosenblatt, Joseph D., Brice, Pauline, Bartlett, Nancy L., Bosly, Andre, Pinter‐Brown, Lauren, Kennedy, Dana, Sievers, Eric L., Gopal, Ajay K.
Published in British journal of haematology (01.07.2009)
Published in British journal of haematology (01.07.2009)
Get full text
Journal Article
A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
DUVIC, Madeleine, REDDY, Sunil A, PINTER-BROWN, Lauren, KORMAN, Neil J, ZIC, John, KENNEDY, Dana A, LORENZ, Jennie, SIEVERS, Eric L, KIM, Youn H
Published in Clinical cancer research (01.10.2009)
Published in Clinical cancer research (01.10.2009)
Get full text
Journal Article
Brentuximab Vedotin in Transplant‐Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies
Forero‐Torres, Andres, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L., Rosenblatt, Joseph D., Kennedy, Dana A., Younes, Anas
Published in The oncologist (Dayton, Ohio) (01.08.2012)
Published in The oncologist (Dayton, Ohio) (01.08.2012)
Get full text
Journal Article
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting
Gopal, Ajay K, Pro, Barbara, Connors, Joseph M, Younes, Anas, Engert, Andreas, Shustov, Andrei R, Chi, Xuedong, Larsen, Emily K, Kennedy, Dana A, Sievers, Eric L
Published in Clinical trials (London, England) (01.10.2016)
Published in Clinical trials (London, England) (01.10.2016)
Get more information
Journal Article
Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma
Foyil, Kelley V., Kennedy, Dana A., Grove, Laurie E., Bartlett, Nancy L., Cashen, Amanda F.
Published in Leukemia & lymphoma (01.03.2012)
Published in Leukemia & lymphoma (01.03.2012)
Get full text
Journal Article
191P4D12 단백질에 결합하는 항체 약물 접합체(ADC)로 암을 치료하는 방법
GARTNER ELAINA MARIE, CHOWN ERIC JOHN, KENNEDY DANA ANN, KIM HAFKEN TINA
Year of Publication 13.07.2023
Get full text
Year of Publication 13.07.2023
Patent
Abstract DDT02-04: SGN-CD33A: Preclinical and phase 1 interim clinical trial results of a CD33-directed PBD dimer antibody-drug conjugate for the treatment of acute myeloid leukemia (AML)
Kennedy, Dana A., Alley, Stephen C., Zhao, Baiteng, Feldman, Eric J., O'Meara, Megan, Sutherland, May
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Phase 3 trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+ mature T-cell lymphomas (MTCL)
O'Connor, Owen A., Pro, Barbara, Illidge, Tim, Trumper, Lorenz H., Larsen, Emily K., Kennedy, Dana A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article